These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36066033)
1. Increased Endotoxin Activity in COVID-19 Patients Admitted to the Intensive Care Unit. Dela Cruz PTH; Davison D; Yamane DP; Chu E; Seneff M J Intensive Care Med; 2023 Jan; 38(1):27-31. PubMed ID: 36066033 [TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study. Lowe R; Ferrari M; Nasim-Mohi M; Jackson A; Beecham R; Veighey K; Cusack R; Richardson D; Grocott M; Levett D; Dushianthan A; BMC Nephrol; 2021 Mar; 22(1):92. PubMed ID: 33722189 [TBL] [Abstract][Full Text] [Related]
3. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series. Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288 [TBL] [Abstract][Full Text] [Related]
4. Endotoxemia in pediatric critical illness--a pilot study. Dholakia S; Inwald D; Betts H; Nadel S Crit Care; 2011; 15(3):R141. PubMed ID: 21651808 [TBL] [Abstract][Full Text] [Related]
5. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil. Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806 [TBL] [Abstract][Full Text] [Related]
6. Endotoxemia in Critically Ill Patients with COVID-19. Khan S; Bolotova O; Sahib H; Foster D; Mallipattu SK Blood Purif; 2022; 51(6):513-519. PubMed ID: 34515062 [TBL] [Abstract][Full Text] [Related]
7. Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: Case series from EUPHAS2 registry. De Rosa S; Cutuli SL; Ferrer R; Antonelli M; Ronco C; Artif Organs; 2021 Jun; 45(6):E187-E194. PubMed ID: 33377184 [TBL] [Abstract][Full Text] [Related]
8. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Marshall JC; Walker PM; Foster DM; Harris D; Ribeiro M; Paice J; Romaschin AD; Derzko AN Crit Care; 2002 Aug; 6(4):342-8. PubMed ID: 12225611 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of the endotoxin activity assay as a biomarker to assess the severity of endotoxemia in critically ill patients. Ikeda T; Ikeda K; Suda S; Ueno T Innate Immun; 2014 Nov; 20(8):881-7. PubMed ID: 24398861 [TBL] [Abstract][Full Text] [Related]
11. Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study. Hsu CM; Gupta S; Tighiouart H; Goyal N; Faugno AJ; Tariq A; Raichoudhury R; Sharma JH; Meyer L; Kshirsagar RK; Jose A; Leaf DE; Weiner DE; Am J Kidney Dis; 2022 Mar; 79(3):404-416.e1. PubMed ID: 34871701 [TBL] [Abstract][Full Text] [Related]
12. MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19. Roedl K; Jarczak D; Fischer M; Haddad M; Boenisch O; de Heer G; Burdelski C; Frings D; Sensen B; Karakas M; Kluge S; Nierhaus A Biomarkers; 2021 Jul; 26(5):417-424. PubMed ID: 33754916 [TBL] [Abstract][Full Text] [Related]
13. Early Renal-Replacement Therapy May Reduce the All-Cause Mortality of Severe COVID-19: An Observational Cohort Study. Qian J; Wang M; You H; Luo J; Li S; Chen S; Chen Y; Li X; Wang K; Zhang W; Yuan L; Ni L; Chen J Blood Purif; 2022; 51(12):1006-1014. PubMed ID: 35526521 [TBL] [Abstract][Full Text] [Related]